Stay updated with breaking news from Patrickj Haley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com upgraded shares of Exelixis (NASDAQ:EXEL – Get Rating) from a hold rating to a buy rating in a research note released on Wednesday. Several other analysts also recently issued reports on the stock. Piper Sandler reissued an overweight rating and set a $32.00 target price on shares of Exelixis in a research note on […]
Should You Buy or Sell Exelixis Stock? Get The Latest EXEL Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.
Northern Trust Corp trimmed its position in shares of Exelixis, Inc. (NASDAQ:EXEL – Get Rating) by 1.2% during the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 2,443,152 shares of the biotechnology company’s stock after selling 29,166 shares during the quarter. Northern Trust Corp’s holdings in Exelixis were worth $50,867,000 as of its most […]
Treasurer of the State of North Carolina increased its holdings in shares of Exelixis, Inc. (NASDAQ:EXEL – Get Rating) by 1.6% during the 1st quarter, HoldingsChannel reports. The firm owned 114,029 shares of the biotechnology company’s stock after purchasing an additional 1,805 shares during the period. Treasurer of the State of North Carolina’s holdings in […]
M&T Bank Corp bought a new stake in Exelixis, Inc. (NASDAQ:EXEL – Get Rating) during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 9,992 shares of the biotechnology company’s stock, valued at approximately $228,000. Other hedge funds and other institutional investors […]